Novel monohydroxamate drugs attenuate myocardial reperfusion-induced arrhythmias

Medicine & Life Sciences

• Antioxidants 6%
• Cardiac Arrhythmias 41%
• Deferoxamine 51%
• Heart 31%
• Incidence 7%
• Iron 6%
• Ischemia 24%
• Isolated Heart Preparation 11%
• Myocardial Reperfusion 61%
• N-methyl acetohydroxamic acid 100%
• N-methyl butyrohydroxamic acid 40%
• N-methyl hexanoylhydroxamic acid 39%
• Pharmaceutical Preparations 20%
• Reperfusion 43%
• Ventricular Fibrillation 17%
• Ventricular Tachycardia 17%

Chemical Compounds

• Acetohydroxamic Acid 75%
• Acid 12%
• Antioxidant Agent 9%
• Desferrioxamine 54%
• Drug 25%
• Reduction 22%